Startup Blackfield Supporting AstraZeneca with Genomics, Computational Biology Services | GenomeWeb

NEW YORK (GenomeWeb News) – German startup biotech firm Blackfield today announced a collaboration with AstraZeneca in support of one of the biopharmaceutical firm's oncology drug development programs.

Blackfield will apply its genomics technologies and computational biology capabilities to validate preclinical models in support of AstraZeneca's program it said. Further details of AstraZeneca's program were not revealed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: ancient Ethiopian genome indicates greater Eurasian backflow into Africa, sequencing to diagnose cutaneous T cell lymphoma, and more.

The US House of Representatives science committee has passed a bill to require NSF to ensure it only funds projects that are in the national interest.

DuPont teams with genome editing firm Caribou Biosciences for agricultural applications of the technology.

A blogger reviews her experience learning about her gut microbiome by shipping a sample to uBiome.

Sponsored by
Oracle Health Sciences

Brian Wells of Penn Medicine will detail how his team's "PennOmics" integrated healthcare data warehouse accelerates clinical trial recruitment at the point of care, accepts data from wearables, and does it all in a secure, HIPAA- and research-compliant fashion.